Drug intelligence / Profile preview

Carotilen

Development stage: Unknown
Lead developer: Nika Pharmaceuticals
Modality: Small Molecules
Administration: Oral

Overview

Carotilen is a dietary supplement developed by Nika Pharmaceuticals, Inc. (NKPH) through its subsidiary Nika Europe Ltd. The product has been manufactured and launched in the Bulgarian market as part of the company's portfolio of health supplements. While specific details regarding its active ingredients—likely related to carotenoids given the nomenclature—and biological targets are not extensively documented in clinical literature, the product is positioned for commercial distribution in Europe. Nika Pharmaceuticals consolidated its operations through a merger with Nika BioTechnology in 2024 to streamline the development and commercialization of its pharmaceutical and nutraceutical offerings.

Brand names: Carotilen

Beyond the preview

Go deeper on Carotilen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Carotilen.

Explore the full profile